Testing effectiveness (Phase 2)Study completedNCT03313037
What this trial is testing
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age
Who this might be right for
Pneumococcal Infections
Pfizer 444